Katherine Szarama, Ph.D., will…
Katherine Szarama, Ph.D., will take over as CBER director in [...]
Viking Therapeutics’…
Viking Therapeutics’ collaboration with Ligand Pharmaceuticals has sailed into some [...]
Johnson & Johnson has dropped…
Johnson & Johnson has dropped a pair of CAR-T cell [...]
“We want to develop those programs…
“We want to develop those programs as far as we [...]
Amgen has pulled the plug on…
Amgen has pulled the plug on midstage drug candidates for [...]
After last month’s departure of…
After last month’s departure of longtime executive Adam Pearson, Astellas [...]
An FDA expert panel on Thursday…
An FDA expert panel on Thursday voted 6 to 3 [...]
Bristol Myers Squibb has called…
Bristol Myers Squibb has called time on a bispecific antibody [...]
Indivior ended internal…
Indivior ended internal development of an opioid use disorder candidate [...]
BeOne Medicines is paying $20…
BeOne Medicines is paying $20 million upfront to reserve the [...]